Skip to main content
. 2021 Jun 29;125(6):816–825. doi: 10.1038/s41416-021-01470-2

Fig. 3. Forest plot of progression-free survival for anti-EGFR treatment recipients with left-sided colon versus middle/low rectal tumours among different subgroups.

Fig. 3

EGFR epidermal growth factor receptor, AJCC American Joint Committee on Cancer staging system, CEA carcinoembryonic antigen, CA199 carbohydrate antigen 19-9, HR hazard ratio, CI confidence interval.